Cite
MLA Citation
Robert Mason et al.. “Combined ipilimumab and nivolumab first‐line and after BRAF‐targeted therapy in advanced melanoma.” Pigment cell & melanoma research, vol. 33, 2020, pp. 358–365. http://access.bl.uk/ark:/81055/vdc_100134036668.0x000021